BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 15179825)

  • 21. How thin can glass be? New ideas, new approaches.
    Keough K
    Biophys J; 2003 Nov; 85(5):2785-6. PubMed ID: 14581183
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular dynamics simulations of lung surfactant lipid monolayers.
    Rose D; Rendell J; Lee D; Nag K; Booth V
    Biophys Chem; 2008 Dec; 138(3):67-77. PubMed ID: 18845376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol modifies the properties of surface films of dipalmitoylphosphatidylcholine plus pulmonary surfactant-associated protein B or C spread or adsorbed at the air-water interface.
    Taneva S; Keough KM
    Biochemistry; 1997 Jan; 36(4):912-22. PubMed ID: 9020791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifying calf lung surfactant by hexadecanol.
    Alonso C; Bringezu F; Brezesinski G; Waring AJ; Zasadzinski JA
    Langmuir; 2005 Feb; 21(3):1028-35. PubMed ID: 15667185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermodynamic and structural characterization of a mixed perfluorocarbon-phospholipid ternary monolayer surfactant system.
    Eftaiha AF; Brunet SM; Paige MF
    J Colloid Interface Sci; 2012 Feb; 368(1):356-65. PubMed ID: 22047922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ternary bilayer mixtures with asymmetric or symmetric unsaturated phosphatidylcholine lipids by coarse grained molecular dynamics simulations.
    Rosetti C; Pastorino C
    J Phys Chem B; 2012 Mar; 116(11):3525-37. PubMed ID: 22369354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the in situ structural and interfacial properties of the cationic hydrophobic heteropolypeptide, KL4, in lung surfactant bilayer and monolayer models at the air-water interface: implications for pulmonary surfactant delivery.
    Mansour HM; Damodaran S; Zografi G
    Mol Pharm; 2008; 5(5):681-95. PubMed ID: 18630875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interfacial behavior of pulmonary surfactant preparations containing egg yolk lecithin.
    Nakahara H; Shibata O
    J Oleo Sci; 2014; 63(11):1159-68. PubMed ID: 25296574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant-spreading and surface-compression disturbance on a thin viscous film.
    Bull JL; Nelson LK; Walsh JT; Glucksberg MR; Schürch S; Grotberg JB
    J Biomech Eng; 1999 Feb; 121(1):89-98. PubMed ID: 10080094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation and modification of exogenous phosphatidylcholines by mycoplasmas.
    Rottem S; Adar L; Gross Z; Ne'eman Z; Davis PJ
    J Bacteriol; 1986 Jul; 167(1):299-304. PubMed ID: 3087959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unsaturated phosphatidylcholines lining on the surface of cartilage and its possible physiological roles.
    Chen Y; Crawford RW; Oloyede A
    J Orthop Surg Res; 2007 Aug; 2():14. PubMed ID: 17718898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Fourier transform infrared spectrometry study of the reactions of phosphatidylcholines with gaseous N2O5 and NO2.
    Finlayson-Pitts BJ; Sweetman LL; Weissbart B
    Toxicol Appl Pharmacol; 1987 Jul; 89(3):438-48. PubMed ID: 3603571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exclusion of fluid lipid during compression of monolayers of mixtures of dipalmitoylphosphatidylcholine with some other phosphatidylcholines.
    Hawco MW; Coolbear KP; Davis PJ; Keough KM
    Biochim Biophys Acta; 1981 Aug; 646(1):185-7. PubMed ID: 6895038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Langmuir-Blodgett multilayers of phosphatidic acid and mixed phospholipids.
    Hasmonay H; Caillaud M; Dupeyrat M
    Biochem Biophys Res Commun; 1979 Jul; 89(2):338-44. PubMed ID: 582667
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pulmonary surfactant: its relation to the type of pneumonia and adrenal gland function in children in their first year of life].
    Magrupov BA; Mavlianov IR; Rafaĭlova LD; Umarbekova NI; Alekseevskikh IuG
    Pediatriia; 1992; (1):111. PubMed ID: 1614795
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantitative analysis of phosphatidylcholine molecular species using HPLC and light scattering detection.
    Brouwers JF; Gadella BM; van Golde LM; Tielens AG
    J Lipid Res; 1998 Feb; 39(2):344-53. PubMed ID: 9507995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A critical assessment of the Wilhelmy method in studying lung surfactants.
    Barrow RE; Hills BA
    J Physiol; 1979 Oct; 295():217-27. PubMed ID: 583285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phosphatidylcholine as the basis for artificial pulmonary surfactants: comparison of surface active properties].
    Khalilov EM; Torkhovskaia TI; Zakharova TS; Kochetova MM; Zdeshnev VO
    Biomed Khim; 2004; 50(2):180-6. PubMed ID: 15179825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of antitubercular drugs on dipalmitoylphosphatidylcholine monolayers: implications for drug loaded surfactants.
    Chimote G; Banerjee R
    Respir Physiol Neurobiol; 2005 Jan; 145(1):65-77. PubMed ID: 15652789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of distribution characteristics of phosphatidylcholines and surfactant preparation.
    Zakharova TS; Fortinskaya ES; Kochetova MM; Torkhovskaya TI; Khalilov EM
    Bull Exp Biol Med; 2000 Apr; 129(4):348-9. PubMed ID: 10977915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.